PubRank

Robert Voswinckel

Author PubWeight™ 56.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 2003 3.81
2 Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. J Am Coll Cardiol 2010 2.55
3 Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice. Cell 2011 2.51
4 Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006 1.76
5 Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am J Respir Crit Care Med 2009 1.58
6 p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J 2002 1.46
7 Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension. FASEB J 2005 1.44
8 Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. J Am Coll Cardiol 2004 1.42
9 The prognostic significance of inspiratory capacity in pulmonary arterial hypertension. Respiration 2014 1.41
10 Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2012 1.29
11 Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy. Circulation 2007 1.28
12 Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-/- mice. Hepatology 2010 1.22
13 Contrasting expression of canonical Wnt signaling reporters TOPGAL, BATGAL and Axin2(LacZ) during murine lung development and repair. PLoS One 2011 1.20
14 The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol 2008 1.19
15 Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension. J Am Coll Cardiol 2006 1.11
16 Perioperative mortality in patients with pulmonary hypertension undergoing major joint replacement. Anesth Analg 2010 1.10
17 Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke-induced emphysema in mice. J Clin Invest 2011 1.10
18 Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. J Heart Lung Transplant 2011 1.09
19 CD34+ progenitor to endothelial cell transition in post-pneumonectomy angiogenesis. Am J Respir Cell Mol Biol 2011 1.05
20 Participation of bone marrow-derived cells in long-term repair processes after experimental stroke. J Cereb Blood Flow Metab 2003 1.05
21 The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells. Exp Hematol 2002 0.99
22 Polycomb group protein Bmi1 is required for growth of RAF driven non-small-cell lung cancer. PLoS One 2009 0.95
23 Identification of right heart-enriched genes in a murine model of chronic outflow tract obstruction. J Mol Cell Cardiol 2010 0.95
24 Endothelin-1 inhibits background two-pore domain channel TASK-1 in primary human pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol 2009 0.95
25 Role of epidermal growth factor inhibition in experimental pulmonary hypertension. Am J Respir Crit Care Med 2009 0.94
26 Phenotypical and ultrastructural features of Oct4-positive cells in the adult mouse lung. J Cell Mol Med 2014 0.94
27 Analysis of tumor vessel supply in Lewis lung carcinoma in mice by fluorescent microsphere distribution and imaging with micro- and flat-panel computed tomography. Am J Pathol 2005 0.93
28 Characterization of a novel fibroblast growth factor 10 (Fgf10) knock-in mouse line to target mesenchymal progenitors during embryonic development. PLoS One 2012 0.92
29 Bone marrow transplantation improves hepatic fibrosis in Abcb4-/- mice via Th1 response and matrix metalloproteinase activity. Gut 2011 0.90
30 HIF-1alpha attenuates tumor growth in spite of augmented vascularization in an A549 adenocarcinoma mouse model. Int J Oncol 2005 0.89
31 Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia. Thromb Haemost 2005 0.88
32 Myocardial remodelling in left ventricular atrophy induced by caloric restriction. J Anat 2011 0.87
33 Hypoxia- and non-hypoxia-related pulmonary hypertension - established and new therapies. Cardiovasc Res 2006 0.87
34 Spatiotemporal expression of flk-1 in pulmonary epithelial cells during lung development. Am J Respir Cell Mol Biol 2008 0.85
35 Senescence-associated secretory phenotype and its possible role in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2014 0.84
36 Treprostinil inhibits the adhesion and differentiation of fibrocytes via the cyclic adenosine monophosphate-dependent and Ras-proximate protein-dependent inactivation of extracellular regulated kinase. Am J Respir Cell Mol Biol 2011 0.84
37 HbA1c in pulmonary arterial hypertension: a marker of prognostic relevance? J Heart Lung Transplant 2012 0.83
38 Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol 2011 0.83
39 Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice. BMC Pulm Med 2010 0.82
40 Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis. Respir Res 2010 0.82
41 Short-term improvement in pulmonary hemodynamics is strongly predictive of long-term survival in patients with pulmonary arterial hypertension. Pulm Circ 2013 0.82
42 Krüppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency. Orphanet J Rare Dis 2012 0.80
43 Inhaled treprostinil [corrected] for treatment of chronic pulmonary arterial hypertension. Ann Intern Med 2006 0.80
44 Dynamic hyperinflation during exercise in patients with precapillary pulmonary hypertension. Respir Med 2011 0.80
45 Quantitative proteome analysis of alveolar type-II cells reveals a connection of integrin receptor subunits beta 2/6 and WNT signaling. J Proteome Res 2013 0.78
46 Inhaled treprostinil: a therapeutic review. Drug Des Devel Ther 2012 0.78
47 Pulmonary Hemodynamic Response to Exercise in Chronic Thromboembolic Pulmonary Hypertension before and after Pulmonary Endarterectomy. Respiration 2015 0.78
48 The number of cardiac myocytes in the hypertrophic and hypotrophic left ventricle of the obese and calorie-restricted mouse heart. J Anat 2014 0.77
49 17β-estradiol replacement reverses age-related lung disease in estrogen-deficient C57BL/6J mice. Endocrinology 2013 0.76
50 Riociguat for pulmonary hypertension. Future Cardiol 2010 0.75
51 Air travel can be safe and well tolerated in patients with clinically stable pulmonary hypertension. Pulm Circ 2011 0.75
52 [Emerging therapies for the treatment of pulmonary arterial hypertension]. Herz 2005 0.75